Greenleaf Trust’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,204
Closed -$224K 733
2022
Q1
$224K Sell
6,204
-2,566
-29% -$126K ﹤0.01% 692
2021
Q4
$672K Buy
8,770
+3,172
+57% +$280K 0.01% 336
2021
Q3
$538K Sell
5,598
-283
-5% -$30.9K 0.01% 368
2021
Q2
$628K Sell
5,881
-55
-0.9% -$5.41K 0.01% 337
2021
Q1
$532K Sell
5,936
-26
-0.4% -$2.86K 0.01% 360
2020
Q4
$599K Buy
5,962
+26
+0.4% +$1.94K 0.01% 287
2020
Q3
$290K Hold
5,936
﹤0.01% 426
2020
Q2
$242K Buy
+5,936
New +$171K ﹤0.01% 451

Other funds holding CRNC

Greenleaf Trust's CRNC Position: Q2 2022 in Review

Greenleaf Trust sold out of Cerence (CRNC) in Q2 2022, closing a stake of 6,204 shares — an estimated $224K sold.

Greenleaf Trust first reported a position in CRNC in Q2 2020 and held it in 8 quarters. The position peaked at $672K in Q4 2021. 270 funds tracked by Wall St. Rank hold CRNC as of Q2 2022.

  • Greenleaf Trust reported no remaining Cerence position as of Q2 2022 after selling out during the quarter.
  • Greenleaf Trust sold 6,204 Cerence shares in Q2 2022, an estimated $224K.
  • Greenleaf Trust first reported a position in Cerence in Q2 2020 and held it in 8 quarters.
  • Greenleaf Trust's Cerence position peaked at $672K in Q4 2021.
  • 270 funds tracked by Wall St. Rank held Cerence as of Q2 2022.

Based on Greenleaf Trust's 13F filing for Q2 2022, filed 12 Aug 2022.